STOCK TITAN

Verano Announces Conference Participation for November

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Verano Holdings Corp. (CSE: VRNO; OTCQX: VRNOF) will present at two upcoming cannabis conferences. Aaron Miles, Chief Investment Officer, will speak at Grizzle Cannabis Con on November 23, 2021, at 10:20 a.m. CT. Following this, George Archos, Founder and CEO, will participate in the Cowen 4th Annual Cannabis Conference on November 29, 2021, also at 10:20 a.m. CT. Verano is a leading multi-state cannabis operator in the U.S., operating in 12 states with over 1,000,000 square feet of cultivation space.

Positive
  • Participation in two upcoming cannabis industry conferences could enhance visibility and investor interest.
  • Verano operates in 12 states, demonstrating its significant market presence.
  • The company's extensive cultivation space of over 1,000,000 square feet supports scalability and production capacity.
Negative
  • None.

CHICAGO, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced that members of its executive leadership team will present at the following conferences:

Grizzle Cannabis Con
Aaron Miles, Chief Investment Officer, will participate in a presentation.
DATE: November 23, 2021
TIME: 10:20 a.m. CT
LINK: https://youtu.be/jgXslDIKQyQ

Cowen 4th Annual Cannabis Conference (Private Event)
George Archos, Founder and Chief Executive Officer, will participate in a panel discussion and one-on-one meetings.
DATE: November 29, 2021
TIME: 10:20 a.m. CT

About Verano

Verano is a leading, vertically integrated, multi-state cannabis operator in the U.S., devoted to the ongoing improvement of communal wellness by providing responsible access to regulated cannabis products. With a mission to address vital health and wellness needs, Verano produces a comprehensive suite of premium, innovative cannabis products sold under its trusted portfolio of consumer brands, including Verano, Avexia, Encore, and MÜV. Verano’s portfolio encompasses 15 U.S. states, with active operations in 12, including 12 production facilities comprising over 1,000,000 square feet of cultivation. Verano designs, builds, and operates dispensaries under retail brands including Zen Leaf and MÜV, delivering a superior cannabis shopping experience in both medical and adult-use markets. Learn more at www.verano.com.

Forward Looking Statements

This press release contains certain "forward-looking information" within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company's control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or may contain statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "will continue", "will occur" or "will be achieved". The forward-looking information and forward-looking statements contained herein include, but are not limited to, statements or information with respect to the Company’s position in the marketplace, the timeline associated with the lifting of certain contractual lockups, potential stock performance, and the delivery of value for our stakeholders.

Forward-looking information and statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking information and statements herein, including, without limitation, the risk factors discussed in the Company's filings on SEDAR at www.sedar.com.

The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information or forward-looking statements that are contained or referenced herein, except as may be required in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice regarding forward-looking information and statements.

# # #

Contacts:
Investors
Verano
Julianna Paterra, CFA
Director, Investor relations
julianna@verano.holdings
Media
Verano Holdings Corp.
Steve Mazeika
Director, Communications
Steve.Mazeika@verano.com
312-348-4430


FAQ

When is Verano presenting at Grizzle Cannabis Con?

Verano will present at Grizzle Cannabis Con on November 23, 2021, at 10:20 a.m. CT.

Who from Verano is speaking at the Cowen 4th Annual Cannabis Conference?

George Archos, Founder and CEO of Verano, will participate in a panel discussion and one-on-one meetings at the Cowen 4th Annual Cannabis Conference on November 29, 2021.

What is the stock symbol for Verano Holdings?

Verano Holdings trades under the stock symbol VRNOF on the OTCQX.

How many states does Verano operate in?

Verano operates in 12 states across the U.S.

What is the cultivation capacity of Verano?

Verano has over 1,000,000 square feet of cultivation space.

VERANO HLDGS CORP

OTC:VRNOF

VRNOF Rankings

VRNOF Latest News

VRNOF Stock Data

1.32B
259.21M
16.07%
11.02%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Chicago